Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,6403891,accumulation half-life,"N-desmethylmethsuximide was the principal substance detected in plasma and had the following pharmacokinetic values: accumulation half-life, 49.7 hours; time to steady state, 10.4 days; elimination half-life, 72.2 hours; therapeutic range of plasma concentration, 10 to 30 mg per liter.","Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6403891/),h,49.7,52153,DB05246,Methsuximide
,6403891,time to steady state,"N-desmethylmethsuximide was the principal substance detected in plasma and had the following pharmacokinetic values: accumulation half-life, 49.7 hours; time to steady state, 10.4 days; elimination half-life, 72.2 hours; therapeutic range of plasma concentration, 10 to 30 mg per liter.","Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6403891/),d,10.4,52154,DB05246,Methsuximide
,6403891,elimination half-life,"N-desmethylmethsuximide was the principal substance detected in plasma and had the following pharmacokinetic values: accumulation half-life, 49.7 hours; time to steady state, 10.4 days; elimination half-life, 72.2 hours; therapeutic range of plasma concentration, 10 to 30 mg per liter.","Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. ","t1/2,Î²-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/6403891/),h,72.2,52155,DB05246,Methsuximide
,577506,half-life,"The metabolite accounted for 40% of the overall elimination of methsuximide, and the half-life of the metabolite (15 hr) was much greater than that of the parent drug (1--3.5 hr).",Pharmacokinetics of methsuximide and a major metabolite in dogs. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/577506/),h,15,177209,DB05246,Methsuximide
,577506,half-life,"The metabolite accounted for 40% of the overall elimination of methsuximide, and the half-life of the metabolite (15 hr) was much greater than that of the parent drug (1--3.5 hr).",Pharmacokinetics of methsuximide and a major metabolite in dogs. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/577506/),h,1--3.5,177210,DB05246,Methsuximide
